What's breaking now, across thousands of outlets.
(RTTNews) - Friday, Eli Lilly (LLY) reported new exploratory Phase 3b data from the TOGETHER-PsO study evaluating Taltz (ixekizumab) and Zepbound (tirzepatide) in adults with psoriasis and obesity or overweight.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
Health and power are "deeply connected for women", according to Melinda French Gates, who says the world is "way behind on women's health".
WELTRUZA™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous long-acting injectable (LAI) formulation of olanzapine for the treatment of…
Video games have become an easy target in conversations about young people's mental health, often without much understanding of the positive role they can play.
KUALA LUMPUR, Oct 9 — Healthcare stakeholders had mixed responses to the national health allocations announced in...
KUALA LUMPUR, Oct 9 — Healthcare stakeholders had mixed responses to the national health allocations announced in...
The death of a lab worker in Russia has raised fears of the plague. Authorities claim she died of pneumonia from an unknown origin, but have yet to release any other details surrounding if there’s a…
